Analysts anticipate Core Scientific will report Q2 2026 revenue of approximately $144.90 million and a consensus EPS of -$0.02, with the current stock price of $19.69 sitting significantly below the $37.13 average analyst target.
The primary focus for investors remains the company's large-scale transition into high-density colocation (HDC) for AI and high-performance computing, which represents a decisive shift from its legacy Bitcoin mining operations.
This evolution is underscored by a recent 15-year partnership with AMD for 530 megawatts of capacity and an expanded CoreWeave deal, collectively targeting over $24 billion in potential contracted revenue. Analysts are monitoring the delivery timelines for these data center campuses and the resulting impact on the company's long-term margin profile.